Fonte: Radiation Oncology. Unidade: FM
Assuntos: NEOPLASIAS RETAIS, QUIMIOTERAPIA ADJUVANTE, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HABR-GAMA, Angelita et al. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen. Radiation Oncology, n. 24, p. 8 , 2016Tradução . . Disponível em: http://ro-journal.biomedcentral.com/articles/10.1186/s13014-016-0598-6. Acesso em: 03 nov. 2025.APA
Habr-Gama, A., Perez, R. O., São Julião, G. P., Proscurshim, I., Fernandez, L. M., Figueiredo, M. N., et al. (2016). Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen. Radiation Oncology, ( 24), 8 . doi:10.1186/s13014-016-0598-6NLM
Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Fernandez LM, Figueiredo MN, Gama-Rodrigues J, Buchpiguel CA. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen [Internet]. Radiation Oncology. 2016 ;( 24): 8 .[citado 2025 nov. 03 ] Available from: http://ro-journal.biomedcentral.com/articles/10.1186/s13014-016-0598-6Vancouver
Habr-Gama A, Perez RO, São Julião GP, Proscurshim I, Fernandez LM, Figueiredo MN, Gama-Rodrigues J, Buchpiguel CA. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen [Internet]. Radiation Oncology. 2016 ;( 24): 8 .[citado 2025 nov. 03 ] Available from: http://ro-journal.biomedcentral.com/articles/10.1186/s13014-016-0598-6
